NOUV — Nouveau Life Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $1.33m
- $1.66m
Annual income statement for Nouveau Life Pharmaceuticals, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2003 June 30th | 2004 June 30th | 2005 June 30th | 2006 June 30th | 2007 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.255 | 0.311 | 0.402 | 0.257 | 0.357 |
| Operating Profit | -0.255 | -0.311 | -0.402 | -0.257 | -0.357 |
| Net Income Before Taxes | -0.255 | -0.311 | -0.402 | -0.257 | -0.357 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.255 | -0.311 | -0.402 | -0.257 | -0.357 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.255 | -0.311 | -0.402 | -0.257 | -0.357 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.255 | -0.311 | -0.402 | -0.257 | -0.357 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.012 | -0.014 | -0.001 | -0.01 | -0.013 |
| Dividends per Share |